Latest Market News

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Raiz Invest Limited reported robust growth in Q4 FY25, with active customers and funds under management hitting new highs, supported by a strategic partnership with Drip Invest and ongoing product innovation.

PlaySide Studios has raised $6.6 million through a share placement to bolster its balance sheet ahead of the launch of its new original game, MOUSE, P.I. For Hire. The capital raise includes director participation and an upcoming Share Purchase Plan for existing shareholders.

Helloworld Travel has upgraded its FY25 earnings forecast, buoyed by strong cruise sales and robust agent retention despite softer passenger transaction values.

Morris Group has launched a conditional, non-binding takeover proposal for Reef Casino Trust, offering $3.70 per unit, rivaling the existing Iris bid. The Independent Board Committee urges unitholders to hold off while assessing this alternative.

Clarity Pharmaceuticals has completed a $203 million institutional placement at a premium, bolstering its cash reserves to nearly $288 million and positioning the company to advance pivotal clinical trials and commercial preparations for its cancer-fighting radiopharmaceuticals.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

AVJennings Limited has issued over 6.7 million shares to satisfy the vesting of performance and retention rights as part of its ongoing acquisition by Proprium Capital Partners and AVID entities.

Noxopharm Limited has successfully completed the first low-dose cohort in its HERACLES clinical trial for SOF-SKN™, clearing the way for higher dose testing in autoimmune disease treatment.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

Centaurus Metals reports strong value engineering results for its Jaguar Nickel Sulphide Project, confirming a 15-year mine life and first quartile costs, while advancing exploration at Boi Novo and Jambreiro iron ore projects.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.